HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Combination strategies and switching CDKs
She considers pairing oral CERDs/PROTACs with CDK4/6 or targeted agents and regulatory limits for combinations.
Play episode from 44:19
Transcript
